Honorary Chair: Dr. Tabaré Vázquez

Dr. Tabaré VázquezThe GTFRCC is extremely fortunate to have as its Honorary Chair, Dr. Tabaré Vázquez, radiation oncologist and statesman. Dr. Vazquez attended medical school at Uruguay’s Universidad de la República and graduated with a specialty in oncology and radiology in 1972. In 2004, Dr. Vazquez was elected President of the Oriental Republic of Uruguay and served for five years beginning March 1, 2005. Even as president, Dr. Vázquez continued his practice, dedicating one morning a week to a Montevideo clinic.

International Secretariat

The International Secretariat will provide oversight and direction to the work of the GTFRCC. Confirmed Secretariat members include:

David JaffrayDavid Jaffray (Head of Secretariat) is Head of Radiation Physics at Princess Margaret Cancer Centre and Senior Scientist within the Ontario Cancer Institute. He is Professor in the Departments of Radiation Oncology and Medical Biophysics, and Vice Chair of the Department of Radiation Oncology at the University of Toronto.

Mary GospodarowiczMary Gospodarowicz is the immediate past-President of UICC. She is Medical Director of the Princess Margaret Cancer Centre at the University Health Network in Toronto, Canada and Regional Vice-President of Cancer Care Ontario for Toronto South. She recently completed a 10 year term as Professor and Chair of the Department of Radiation Oncology at the University of Toronto and Chief of the Radiation Medicine Program at Princess Margaret.

Eduardo RosenblattEduardo Rosenblatt is a radiation oncologist and Section Head of the Applied Radiation Biology and Radiotherapy Section, Division of Human Health, International Atomic Energy Agency in Vienna. Dr. Rosenblatt has published extensively on worldwide radiation therapy capacity.

Bhadrasain VikramBhadrasain Vikram is Chief of the Clinical Radiation Oncology Branch at the NCI (Bethesda, MD) overseeing a portfolio of clinical research grants within the Radiation Research Program as well as assisting the Cancer Therapy Evaluation Program and the Coordinating Center for Clinical Trials with NCI’s cooperative clinical trials groups program.

Michael BartonMichael Barton is Professor of Radiation Oncology at University of New South Wales in Sydney, Austraila. He is also Research Director of the Collaboration for Cancer Outcomes Research and Evaluation (CCORE) and the Research Director of the Ingham Institute at Liverpool Hospital. His major interest is in cancer health services research.

Michael BaumannMichael Baumann is Professor of Radiation Oncology at Technische Universität Dresden (TUD). He is Director of the Interdisciplinary University Cancer Center, and Chairman of the OncoRay-Center for Radiation Research in Oncology. He was President the European Society for Therapeutic Radiology and Oncology (ESTRO) from 2003-2007. He is past President of ECCO – the European Cancer Organisation.

Jake Van Dyk is Professor Emeritus of Oncology and Medical Biophysics, at Western University, London, Ontario, Canada, and former Manager (Chief) of Physics and Engineering at the London Regional Cancer Program (LRCP). He has over 40 years of experience in the practical facets of radiation oncology physics and is a consultant and lecturer for the IAEA. He has won numerous awards for his work in Medical Physics. In May 2014, Western University conferred on him an honorary doctorate.

Felicia M. KnaulFelicia M. Knaul is Associate Professor at Harvard Medical School and Director of the Harvard Global Equity Initiative, where she serves as Secretariat Co-Chair of the Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries. She is a senior economist at the Mexican Health Foundation where she leads a research group on health financing and health system reform in Latin America and the Caribbean region. She is a board member of numerous organizations including the Union for International Cancer Control.

Rifat AtunRifat Atun is Professor of Global Health Systems at the Department of Global Health and Population at Harvard University’s School of Public Health. Dr. Atun has worked extensively with the World Bank, World Health Organization, and the UK Department for International Development on design, implementation and evaluation of health system reform programmes in more than 20 countries, and has advised a number of governments in Europe, Latin America, Central Asia and the Middle East.

Cary AdamsCary Adams Chief Executive Officer, UICC. Mr Adams served as Chief Operating Officer of Lloyds TSB Group International Banking in before becoming CEO of UICC in 2009. Mr Adams and the UICC focus on global advocacy to deliver the World Cancer Declaration targets by 2020, running significant global programmes that address key cancer issues and use their membership reach to bring about the exchange of best practice globally

Julie TorodeJulie Torode is Director of Advocacy and Programmes, Deputy Chief Executive Officer, UICC. In addition to managing some of the UICC flagship publications such as the TNM classification series and the International Journal of Cancer, Dr Torode has also been involved in the UICC World Cancer Day campaigns which focused on improving prevention awareness, the development of paediatric oncology projects in low- and middle-income countries, and cervical cancer prevention and control programmes, especially in Tanzania.

Yolande Lievens is the chair of the Radiation Oncology department of the Ghent University Hospital in Belgium and Professor in Radiation Oncology at the Ghent University. She is the current president of the Doctors College for Radiotherapy in Belgium and president of ESTRO (the European Society for Radiotherapy and Oncology).

Her main clinical interest goes to radiotherapy for thoracic and hematologic malignancies, and for breast cancer. Apart from the clinics, she has always been and remains heavily involved in the organisational aspects of radiotherapy, in fostering the position of radiotherapy in the multidisciplinary oncology context and in the financial and health economic aspects of cancer care. She finally has a major interest for quality issues related to radiotherapy, not only in terms of quality assurance and safety, but also regarding the impact of irradiation treatments on quality of life.